FetalDNA is a non-invasive prenatal screening test (NIPT) that provides for the analysis of free fetal DNA circulating on maternal blood to detect the most common fetal aneuploidies in pregnancy, such as those related to chromosome 21 (Down syndrome), to chromosome 18 (Edwards syndrome), chromosome 13 (Patau syndrome) and X and Y sex chromosomes (Turner syndrome, Klinefelter).
FetalDNA provides 5 levels of investigation, with an increasing degree of detail. From the first – Basic FetalDNA – which investigates the most frequent chromosomal abnormalities such as Down syndrome, Edwards syndrome and Patau syndrome, up to the most advanced – Total Screen FetalDNA – which allows you to have in addition to information about the entire set of Chromosome of the fetus and the structural alterations associated with different pathological conditions with results comparable to the fetal karyotype obtained by invasive diagnostic techniques (Amniocentesis and CVS Test), goes to explore the most important fetal monogenic diseases from beta thalassemia to congenital hearing loss up to achondroplasia and numerous others.
Specifically, Basic FetalDNA is also addressed to those who perform the nuchal translucency in the screening of the first trimester of pregnancy, definitely exceeding the important limits of combined tests (ultrasound and biochemical). This test has a very reasonable cost and provides a response in a very short time.
On request it is possible to obtain free the Rhesus factor of the unborn child.